| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/01/2005 | EP1047710B1 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof |
| 06/01/2005 | EP1042460B1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 06/01/2005 | EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells |
| 06/01/2005 | EP0787189B1 Nucleotide sequences mediating male fertility and method of using same |
| 06/01/2005 | EP0769059B1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 06/01/2005 | EP0656941B1 Methods for producing members of specific binding pairs |
| 06/01/2005 | CN1622999A Method for selecting genetically transformed cells |
| 06/01/2005 | CN1622995A Receptor nucleic acids and polypeptides |
| 06/01/2005 | CN1622994A TGF-beta-specific covalently closed antisense molecule |
| 06/01/2005 | CN1622993A Targeted chromosomal mutagenesis using zinc finger nucleases |
| 06/01/2005 | CN1622957A IFNAR2 mutants, their production and use |
| 06/01/2005 | CN1622956A Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 06/01/2005 | CN1622836A Scaffolds for tissue engineered hair |
| 06/01/2005 | CN1622826A Stimulation of bone growth and cartilage formation with thrombing peptide derivatives |
| 06/01/2005 | CN1622823A Purification of red blood cells by separation and infiltration |
| 06/01/2005 | CN1621517A Dunalella salina3-phosphoglycerol dehydrogenase and sequence encoding same |
| 06/01/2005 | CN1621516A Method for hybridization and fusion of organism germ cell and device thereof |
| 06/01/2005 | CN1621515A Method for adjusting the multiplication of human nerve stem cell cultured in vitro |
| 06/01/2005 | CN1204252C Recombinant gene of soluble part in tumor necrosis factor acceptor and its fusion gene and product |
| 06/01/2005 | CN1204246C Method for forming indoles alkaloid by completely adaptive cell large scale culturing of catharanthus roseus |
| 06/01/2005 | CN1204244C Photosynthesis culturing system and group of photosynthesis culturing system |
| 06/01/2005 | CN1203900C Methods for quenching pathogen inactivators in biological materials |
| 05/31/2005 | US6900371 Pesticidal proteins |
| 05/31/2005 | US6900368 Tomato antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
| 05/31/2005 | US6900304 Emission ratiometric indicators of phosphorylation |
| 05/31/2005 | US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/31/2005 | US6900293 Monoclonal antibodies directed against the microtubule-associated protein tau |
| 05/31/2005 | US6900056 Chemically defined medium for cultured mammalian cells |
| 05/31/2005 | US6900055 Oxygen permeable biocompatible elastomer for propagating viable tissue; tissue engineering |
| 05/31/2005 | US6900054 Propagating preferential oligodendrocytes and/or astrocytes using embryonic neural cell adhesion molecule (E-NCAM) differentiated stem cells for treating neurological or neurodegenerative disease |
| 05/31/2005 | US6900051 Generating insulin secreting cells; obtain mammalian pancreatic tissues, dissociate cells, dedifferentiate into insulin precursor cells, isolate and propagate cells |
| 05/31/2005 | US6900049 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 05/31/2005 | US6900043 Phosphatases which activate map kinase pathways |
| 05/31/2005 | US6900032 Human PTTG polypeptide and method for producing it |
| 05/31/2005 | US6900031 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis |
| 05/31/2005 | US6900027 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents |
| 05/31/2005 | US6900017 Human hematopoietic growth regulatory gene and uses |
| 05/31/2005 | US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies |
| 05/31/2005 | US6899873 Porous, biodegradable polymer; tissue culture |
| 05/31/2005 | US6899863 Method for preparing membrane vesicles |
| 05/31/2005 | US6899813 Method for the production of a blood component composition |
| 05/31/2005 | CA2267157C Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 05/31/2005 | CA2247980C Plastid transformation in arabidopsis thaliana |
| 05/31/2005 | CA2116221C Animal cell culture |
| 05/26/2005 | WO2005047532A1 Improved method of performing genetic analyses on reproductive tract cell samples |
| 05/26/2005 | WO2005047529A1 Methods, compositions, and automated systems for separating rare cells from fluid samples |
| 05/26/2005 | WO2005047497A1 High-titer retroviral packaging cells |
| 05/26/2005 | WO2005047496A1 Cell culture method, three-dimensional cell culture method, three-dimensional tissue, artificial organ and tissue transplantation method |
| 05/26/2005 | WO2005047495A1 Implantable neuronal networks |
| 05/26/2005 | WO2005047494A2 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 05/26/2005 | WO2005047493A2 Nanofibrillar structure and applications including cell and tissue culture |
| 05/26/2005 | WO2005047492A1 Melanocytes in therapy of neurodegenerative diseases |
| 05/26/2005 | WO2005047491A2 Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy |
| 05/26/2005 | WO2005047490A2 Improvements in cell growth |
| 05/26/2005 | WO2005047480A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast |
| 05/26/2005 | WO2005047479A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
| 05/26/2005 | WO2005047472A2 Increasing seed threonine content through alteration of threonine aldolase activity |
| 05/26/2005 | WO2005047466A2 Apparatus and method for tissue engineering |
| 05/26/2005 | WO2005047464A2 Cell culture tool and method |
| 05/26/2005 | WO2005046617A2 Compositions and methods for reducing microbial induced apoptosis |
| 05/26/2005 | WO2005046616A2 Viral propagation system and uses thereof |
| 05/26/2005 | WO2005046614A2 System for treating and preventing breast cancer |
| 05/26/2005 | WO2005046598A2 Culturing and differentiating neural precursor cells |
| 05/26/2005 | WO2005046596A2 Stem cell culture medium and method of using said medium and the cells |
| 05/26/2005 | WO2005046581A2 P18 in stem cell manipulations |
| 05/26/2005 | WO2005046570A2 Human stem cell materials and methods |
| 05/26/2005 | WO2005046445A2 Artificial tissue systems and uses thereof |
| 05/26/2005 | WO2005046327A1 A novel long-term three dimensional culture system |
| 05/26/2005 | WO2005028642A3 Method of culturing cells including the inhibition of the expression of a gene or genes involved in cell cycle control |
| 05/26/2005 | WO2005021711A3 Approach for obtaining monoclonal antibodies to cell surface proteins |
| 05/26/2005 | WO2005021029A3 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
| 05/26/2005 | WO2005010173A3 Keratinocyte culturing method and the use thereof |
| 05/26/2005 | WO2004097039A3 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue |
| 05/26/2005 | WO2004092356A3 Method for obtaining mastocyte lines from porcine tissue and method for production of heparin type molecules |
| 05/26/2005 | WO2004085620A3 Novel attached cell lines |
| 05/26/2005 | WO2004083392A3 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 05/26/2005 | WO2004063341A3 Hematopoietic stem cell niche cells |
| 05/26/2005 | WO2004044217A3 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 05/26/2005 | US20050114955 Inbred corn line PHB00 |
| 05/26/2005 | US20050114954 seed, plants and plant parts; crossing the inbred line with another maize plant |
| 05/26/2005 | US20050114953 Inbred corn line PHCMV |
| 05/26/2005 | US20050114952 Inbred corn line PHCND |
| 05/26/2005 | US20050114935 Soybean variety XB13U05 |
| 05/26/2005 | US20050114934 Soybean variety XB12K05 |
| 05/26/2005 | US20050114933 Uniform homozygosity and phenotypic stability; herbicide resistance to glyphosates; insect and disease resistances; phytophthoira resistance; good height and yield; genetic engineering; crossing with other plants |
| 05/26/2005 | US20050114932 Soybean variety XB17S05 |
| 05/26/2005 | US20050114918 System and method of embryo delivery for manufactured seeds |
| 05/26/2005 | US20050114915 Method for sex biasing spermatozoa |
| 05/26/2005 | US20050114914 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies |
| 05/26/2005 | US20050114912 Model for neurodegenerative disorders |
| 05/26/2005 | US20050113562 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof |
| 05/26/2005 | US20050113329 Contacing cell/body fluid with antibody which binds human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide; for inhibiting tumor growth; gene expression inhibition; immunization |
| 05/26/2005 | US20050113325 Linked/conjugated to lipid, fatty acid, and/or sterol; for inhibiting cancer cell proliferation |
| 05/26/2005 | US20050113304 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression |
| 05/26/2005 | US20050113303 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity |
| 05/26/2005 | US20050113297 Contacting target cell or noncellular molecular entity with phagocytic marker and moiety that binds to a component that is present on or at surface of target cell or noncellular molecular entity, thereby increasing level or density of phagocytic marker on target cell; marker comprises phosphatidylserine |
| 05/26/2005 | US20050113273 Alkaline protease from bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease |
| 05/26/2005 | US20050112765 Genetic engineering polypeptides containing capsids; cell transduction |
| 05/26/2005 | US20050112762 Cell differentiation; cell proliferation; immunotherapy of cancer; infectons; autoimmune diseases |
| 05/26/2005 | US20050112761 making a synthetic cartilage patch by culturing said stromal cell in a differentiation medium to form a chondrocytic cell; introducing said cell to a biocompatible matrix capable of supporting chondrogenesis, culturing, cell secretes a cartilage-specific extracellular matrix component |